MaxCyte, Inc. (MXCT)
NASDAQ · Healthcare
MaxCyte, Inc. Operating Income 2019–2025
MaxCyte, Inc. annual/quarterly operating income history and growth rate from 2019 to 2026. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- MaxCyte, Inc. operating income for the quarter ending March 31, 2026 was -6.2 M, a 49.69% decrease year-over-year.
- MaxCyte, Inc. operating income for the twelve months ending March 31, 2026 was -46.9 M, a 10.32% decrease year-over-year.
- MaxCyte, Inc. annual operating income for 2025 was -51.9 M, a 1.37% increase from 2024.
- MaxCyte, Inc. annual operating income for 2024 was -51.2 M, a 6.00% increase from 2023.
- MaxCyte, Inc. annual operating income for 2023 was -48.3 M, a 76.52% increase from 2022.
- MaxCyte, Inc. annual operating income for 2022 was -27.4 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
MaxCyte, Inc. Operating Income — FAQ
MaxCyte, Inc. (MXCT) operating income over the last 7 years — annual and quarterly figures with year-over-year growth and charts.
What is MaxCyte, Inc.'s operating income?
MaxCyte, Inc. (MXCT) reported operating income of -$52M for fiscal 2025.
Where can I see MXCT's operating income history?
The chart and table above show MaxCyte, Inc.'s operating income by year and by quarter, including the growth rate.